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A B S T R A C T
              Consumption of diets high in fat and/or fructose content promotes tissue in ammation, oxidative stress, andfl
            insulin resistance, activating signals (e.g. NF- B/JNK) that downregulate the insulin cascade. Current evidenceκ
                supports the concept that select avonoids can mitigate obesity and type 2 diabetes (T2D). This work in-fl
             vestigated if supplementation with the anthocyanidins (AC) cyanidin and delphinidin could attenuate the ad-
                verse consequences of consuming a high fat diet (HFD) in mice. Consumption of an AC-rich blend mitigated
            HFD-induced obesity, dyslipidemia and insulin resistance (impaired responses to insulin and glucose). HFD-fed
              mice were characterized by increased liver lipid deposition and in ammation, which were also attenuated uponfl
             AC supplementation. HFD caused liver oxidative stress showing an increased expression of NADPH oxidases,
    generators of superoxide and H 2O2            , and high levels of oxidized lipid-protein adducts. This was associated with
               the activation of the redox sensitive signals IKK/NF- B and JNK1/2, and increased expression of the NF- B-κ κ
              regulated PTP1B phosphatase, all known inhibitors of the insulin pathway. In agreement with an improved
             insulin sensitivity, AC supplementation inhibited oxidative stress, NF- B and JNK activation, and PTP1B over-κ
              expression. Thus, cyanidin and delphinidin consumption either through diet or by supplementation could be a
               positive strategy to control the adverse e ects of Western style diets, including overweight, obesity, and T2D.ff
             Modulation of in ammation, oxidative stress, and NF- B/JNK activation emerge as relevant targets of ACfl κ
 bene cial actions.fi
 1. Introduction
         Overweight and obesity put individuals at risk of major health
        problems including type 2 diabetes (T2D), nonalcoholic fatty liver
       disease (NAFLD) and cardiovascular disease. Consumption of Western
            style diets can be a major contributing factor to the increased rates of
        overweight and obesity in human populations, while consumption of
        select fruits and vegetables could attenuate these conditions. Evidence
          for the latter is con icting when considering overall intakes, types offl
        fruits and vegetables consumed, and other variables associated with
             population studies . On the other hand, a large body of evidence in[1 3]–
        experimental animals suggests a bene t of select phytochemicals pre-fi
           sent in fruits and vegetables in the development of obesity and asso-
        ciated pathologies triggered by consumption of high fructose and/or
  high fat diets.
      Among phytochemicals, anthocyanidins (AC) are avonoids beingfl
        actively investigated for their potential to mitigate unhealthy condi-
        tions, particularly metabolic disorders. In this regard, mounting evi-
          dence supports a potential bene cial action of AC consumption on T2Dfi
       [4] [5]and cardiovascular health . Furthermore, AC-rich food
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         consumption is inversely correlated with overall mortality . AC are[6]
         flavonoids that exist in nature as anthocyanins, the glycosylated forms
          of AC. They provide color to grapes, berries, blueberries, black currants,
          bilberries, purple corn, and black rice, among other fruits and vege-
          tables. With the basic three-ring structure of avonoids, AC are char-fl
             acterized by double bonds in the three rings and a positive charge in the
         B ring on the oxygen atom [7]. D i fferent hydroxyl substitutions in
        number and position de ne di erent AC, e.g. delphinidins, malvidins,fi ff
         and peonidins. These di erences in substitutions can have a majorff
           impact on AC biological actions in animals. In this regard, we recently
        observed that 3-O-glucosides of cyanidin and delphinidin were more
        e cient than malvidin, petunidin and peonidin 3-O-glucosides at in-ffi
       hibiting tumor necrosis factor alpha (TNF )-induced activation ofα
      transcription factor NF- B in Caco-2 cells .κ [8]
       Dietary energy overload can cause tissue in ammation, oxidativefl
          stress, and insulin resistance. Excess fat consumption leads to the ac-
        tivation of in ammatory and redox-regulated events including: i) thefl
         I B kinase (IKK), and downstream the transcription factor NF- B; andκ κ
        ii) the mitogen activated kinase c-jun N-terminal kinase (JNK).
           Activation of both JNK and IKK and the increased expres-[9,10] [11]
        sion of the NF- B-regulated protein tyrosine phosphatase 1B phospha-κ
        tase (PTP1B) downregulate the insulin signaling pathway leading[12]
        to insulin resistance. In ammation, oxidative stress, and chronic NF- Bfl κ
        activation also contribute to other major adverse consequences of
      obesity, e.g. NAFLD and cardiovascular disease .[13 15]–
        Identifying fruits and vegetables and their active components that
        can provide protection against the adverse e ects of consumingff
            Western style diets has the potential to have a major impact on human
       health. Moreover, understanding the mechanisms by which these
          components act modifying cell functions is crucial to de ne public re-fi
        commendations in terms of diets and potential supplementation. This
            work investigated the capacity of a diet enriched in the AC cyanidin and
         delphinidin to mitigate in mice the development of obesity, dyslipi-
         demia, steatosis, and insulin resistance promoted by the chronic con-
           sumption of a HFD. The bene cial e ects of AC were mainly associatedfi ff
        with the attenuation of liver in ammation, oxidative stress, andfl
        downregulation of the redox sensitive JNK and IKK/NF- B. Theseκ
         findings stress the concept that cyanidins and delphinidins can provide
         bene ts against excess fat consumption and its adverse health con-fi
sequences.
   2. Materials and methods
2.1. Materials
      Cholesterol and triglyceride concentrations were determined using
        kits purchased from Wiener Lab Group (Rosario, Argentina). Glucose
          levels were measured using a kit purchased from Sigma-Aldrich Co (St.
       Louis, MO). Concentrations of insulin, glucagon-like peptide-1 (GLP-1),
        gastric inhibitory polypeptide (GIP), leptin and adiponectin were de-
         termined using kits purchased from Crystal Chem Inc. (Downers Grove,
      IL). Antibodies for monocyte chemoattractant protein-1 (MCP-1)
       (#2029), TNF (#11948), phospho (Ser176/180) - IKK / (#2697),α α β
        IKK (#2682), JNK2 (#9258) and -actin (#12620) were obtainedα β
        from Cell Signaling Technology (Danvers, MA). Antibodies for F4/80
        (sc-25830), nitric oxide synthase 2 (NOS2) (sc-649), phospho (Thr183/
          Tyr185) - JNK (sc-6254) and NOX3 (sc-67005) were from Santa Cruz
       Biotechnology (Santa Cruz, CA). Antibodies for 4-hydroxynonenal (4-
     HNE) (ab46545), NOX4 (ab133303) and gp91 phox  (ab129068) were
         from Abcam, Inc. (Cambridge, MA). The antibody for PTP1B (ABS40)
         was from EMD Millipore (Hayward, CA). PVDF membranes were ob-
       tained from BIO-RAD (Hercules, CA). The Enhanced chemilumines-
         cence (ECL) Western blotting system was from Thermo Fisher Scienti cfi
         Inc. (Piscataway, NJ). All other chemicals were purchased from Sigma-
           Aldrich Co (St. Louis, MO). The AC-rich blend was provided by NSE
         Products, Inc. (Provo, UT) and its composition is shown in
  Supplemental Table 1.
     2.2. Determination of AC blend composition
        The AC-rich blend was analyzed using a liquid chromatography
         method as previously described . Brie y, the blend was[16,17] [8] fl
         dissolved in water, ltered through PTFE (0.22 µm) membranes andfi
        separations performed using an Agilent series 1200 instrument (Agilent
        Technologies, Santa Clara, CA) with a Kinetex F5 penta uorophenylfl
          HPLC column (2.6 µm, 100 × 4.6 mm) and SecurityGuard cartridge®
           (PFP, 4.0 × 2.0 mm) (Phenomenex, Torrance, CA). A ow rate offl
            0.70 ml/min and a column temperature of 37 °C was set. The injector
         temperature was 4 °C with an injection volume of 7 μ   l. Detection was
           done by UV Vis DAD (wavelength monitored at 280 and 520 nm) and–
         ESI-MS-MS for mass spectral results. Quanti cation was based on DADfi
          peak area absorbance at 520 nm. A binary gradient was employed
           consisting of 1.0% formic acid (v/v) in water (mobile phase A) and
           1.0% formic acid (v/v) in acetonitrile (mobile phase B). Gradient was as
                  follows: 1% B at 0 min, 7.5% B at 7 min, 7.6% B at 14 min, 10% B at
                   17 min, 12% B at 18.5 min, 30% B at 24 min, 90% B at 25 min, 1% B at
          26 30 min. Mass spectral data were acquired using an Agilent 6430–
      triple-quadrupole mass spectrometer with electrospray injection (Agi-
           lent Technologies, Santa Clara, CA, USA) set to scan mode with the
         following optimal MS/MS source parameters: nebulizer at 40 psi, ca-
             pillary voltage + 4000 V (or 3500 V), gas temperature 325 °C, and−
               fl flow of 5 l/min. Sheath gas was 250 °C and sheath ow of 11 l/min. AC
          were identi ed after ionization in their molecular cation form under MSfi
         positive ion mode. Parent ions ( ) were previously described .m/z [8]
    2.3. Animals and animal care
          All procedures were in agreement with standards for care of la-
             boratory animals as outlined in the NIH Guide for the Care and Use of
      Laboratory Animals; experimental protocols were approved before
 Table 1
     Polyphenol composition of the AC-rich blend.
    Compounds mg/g dry weight extract
  Anthocyanidins Cyanidin 95
 Delphinidin 40
 Peonidin 8
 Malvidin ND
 Petunidin ND
 Pelargonidin ND
   Benzoic acids 3-methylgallate ND
  4-hydroxybenzoic acid ND
  Ferulic acid 0.1
  Fumaric acid ND
  Gallic acid 0.8
  Protocatechuic acid 14.9
   Quinic acid < 0.02
  Shikimic acid ND
   Syringic acid < 0.02
  Vanillic acid 0.4
   Hydroxycinnamates Ca eic acid 1.0ff
  Chlorogenic acid 7.5
 p-Coumaric 3.4
  Sinapinic acid 0.7
  Flavonols Kaempferol-3-galactose ND
 Kaempferol-3-glucose 3.4
  Kaempferol < 0.05
  Naringenin < 0.05
 Quercetin 0.1
 Quercetin-3-galactose 1.2
 Quercetin-3-Rutin 0.1
  catechins Catechin ND
  Epicatechin < 0.001
 Gallocatechins ND
  ND: Not detected.
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         implementation by the University of California, Davis Animal Use and
      Care Administrative Advisory Committee. Procedures were adminis-
          tered under the auspices of the Animal Resource Services of the
   University of California, Davis.
         Healthy male C57BL/6J mice (20 25 g) (10 mice/group) were fed–
           for 14 w either: i) a diet containing approximately 10% total calories
             from fat (Control, C group); ii) the control diet plus 40 mg AC/kg body
          weight (CA group); iii) a diet containing approximately 60% total cal-
            ories from fat (lard) (HF group); or iv) the high fat diet supplemented
            with 2 (HFA2 group), 20 (HFA20 group) or 40 (HFA40 group) mg AC/
  kg body weight.
         Body and food intake were measured weekly throughout the study.
           After 14 w on the dietary treatments, mice were euthanized by cervical
        dislocation, blood was collected from the sub-mandibular vein into
        heparinized tubes, and plasma was obtained after centrifugation at
             1000× for 15 min at 4 °C. Di erent adipose tissue pads, and liver wereg ff
          collected and weighed. Tissues were ash frozen in liquid nitrogen andfl
        then stored at 80 °C for further analysis.−
  2.4. Metabolic measurements
            For insulin tolerance tests (ITT), mice were fasted for 4 h and in-
           jected i.p. with 1 U human insulin/kg body weight. Blood glucose va-
              lues were measured before and at 15, 30, 45, 60, 90 and 120 min post-
         injection. For glucose tolerance tests (GTT), overnight fasted mice were
 injected with         D-glucose (2 g/kg body weight), and blood glucose was
            measured before and at 15, 30, 60, and 120 min post-injection. For both
          tests, glucose levels were measured using a glucometer (Easy Plus II,
            Home Aid Diagnostics Inc, Deer eld Beach, FL). At the end of the study,fi
      plasma total cholesterol, triglycerides, glucose, insulin, adiponectin,
       leptin, GLP-1 and GIP concentrations were determined following
 manufacturer's guidelines.
       2.5. Determination of fecal and liver triglyceride content
         Fecal triglyceride content was measured using a modi ed method tofi
           that proposed by Folch et al. . Fecal samples were collected over[18]
               24 h from single cages (3 4 mice) and dried at 37 °C for 24 h. Dried–
             feces (0.5 g) were ground to a ne powder using a mortar and pestle.fi
         The lipid extraction was performed by homogenizing the fecal powder
         with 500 ml of chloroform-methanol (2:1, v/v) solution. Samples were
             mixed for 5 min and centrifuged at 1000× for 10 min at room tem-g
          perature and the lower liquid phase containing the extracted lipids in
      chloroform-methanol was collected and evaporated overnight. Analysis
         of triglyceride content was performed by saponi cation using a methodfi
          described by Weber et al. with minor modi cations. Brie y, the[19] fi fl
             lipid residue was digested by incubation with 500 µl of a KOH (30% w/
              v):ethanol (1:2 v:v) solution for 30 min at 60 °C. An aliquot (200 µl) was
       combined with 215 µl of 1 M MgCl 2       . After centrifugation for 15 min at
          2000× at room temperature, 2 µl of the supernatant were collectedg
         and analyzed for glycerol content using the enzymatic triglyceride kit
       TG Color GPO/PAP AA (Wiener Lab, Rosario, Argentina).
        Analysis of liver triglyceride content was performed after extraction
         and saponi cation, basically as previously described for feces. Brie y, afi fl
             100 µl aliquot of 10% (w/v) liver homogenate was mixed with 300 µl of
         a KOH (30% w/v):ethanol (1:2, v:v) solution and evaporated overnight
              at 55 °C. The following day, 1 ml of 50% (v/v) ethanol was added and
           samples centrifuged for 5 min at 10,000× at room temperature. Of theg
            resulting supernatant, 200 µl were added with 215 µl of 1 M MgCl 2 and
             placed on ice for 10 min. After centrifugation at 10,000× for 5 min atg
          room temperature, 10 µl of the supernatant were analyzed for trigly-
    ceride content as described above.
 Table 2
                             Metabolic parameters from mice fed for 14 w a control (Control) or a high fat diet (HF), without or with supplementation with 2, 20, or 40 mg AC/kg body weight
                        (HFA2, HFA20, HFA40, CA40). Cholesterol, triglycerides, glucose, and insulin were measured in plasma. Values are shown as means ± SE (n = 10). Values having
          di erent superscripts are signi cantly di erent (p < 0.05, one way ANOVA).ff fi ff
      Parameter Control CA40 HF HFA2 HFA20 HFA40
      Daily food intake (g/d) 3.7 ± 0.2 a   4.1 ± 0.1 c   3.0 ± 0.1 b   3.0 ± 0.1 b   2.8 ± 0.1 b   2.9 ± 0.03b
     Body weight (g) 33.7 ± 0.8a   35.8 ± 1.0 a   44.1 ± 1.8 b   41.6 ± 1.2 bc   41.0 ± 1.2bc   38.1 ± 2.2c
     Brown fat (mg) 149 ± 12 a   213 ± 24b   259 ± 20 b   204 ± 32 cd   201 ± 20 cd   178 ± 20a
     Epididymal fat (g) 1.23 ± 0.10a   1.45 ± 0.15 a   2.36 ± 0.10 b   2.28 ± 0.21 b   2.49 ± 0.09 b   2.22 ± 0.29b
     Visceral fat (g) 0.53 ± 0.10a   0.55 ± 0.07 ac   1.28 ± 0.12 b   1.02 ± 0.12 b   1.16 ± 0.18 b   0.89 ± 0.12c
     Subcutaneous fat (g) 0.98 ± 0.06a   1.59 ± 0.19 a   3.54 ± 0.23 b   2.78 ± 0.36 b   3.43 ± 0.27 b   2.71 ± 0.49b
     Retroperitoneal fat (g) 0.40 ± 0.27a   0.54 ± 0.07 a   1.26 ± 0.09 b   0.95 ± 0.07 cb   1.25 ± 0.15 b   0.84 ± 0.13c
     Total cholesterol (mg/dl) 126 ± 3a   134 ± 5 a   160 ± 3b   147 ± 7 b   156 ± 6 b   138 ± 5a
    Triglycerides (mg/dl) 84 ± 2a   84 ± 2a   92 ± 1 b   86 ± 2a   86 ± 3a   86 ± 2a
     Fasted glucose (mg/dl) 164 ± 8a   200 ± 12a   230 ± 11 b   206 ± 17b   225 ± 11b   161 ± 13a
     Fasted insulin (ng/ml) 0.53 ± 0.04ac   0.47 ± 0.04 c   1.22 ± 0.10 b   0.88 ± 0.20 a   1.08 ± 0.24 b   0.61 ± 0.10ac
          Fig. 1. E ects of supplementation with an AC-rich blend on metabolic
            parameters in HFD-fed rats. A- B-Food intake and body weight gain. Mice
           were fed a control diet (empty triangles), the control diet supplemented with
             40 mg AC/kg body weight (full triangles), a HFD (black circles), or the HFD
            supplemented with 2 (light pink diamonds), 20 (dark pink diamonds), or 40 mg
              AC/kg body weight (red circles). Results are shown as means ± SE and are the
          average of 9 10 animals/group. Di erences between the HF and HFA40 body– ff
            weight gain values are signi cant between weeks 4 and 14 on the dietsfi
     (p < 0.05, repeated measures ANOVA).
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  2.6. Histological analyses
          The liver was removed and samples xed overnight in 4% (w/v)fi
     neutralized paraformaldehyde solution. Samples were subsequently
         washed twice in phosphate bu er saline solution, dehydrated, and thenff
         embedded in para n for histological analysis. Sections (5 µm thick-ffi
          ness) were obtained from para n blocks and placed on glass slides.ffi
       Hematoxylin and eosin staining was performed following standard
        procedures. Sections were examined using an Olympus BX51 micro-
        scope (Olympus America Inc., Center Valley, PA). Hepatic histological
         examination was performed using the NAFLD activity score (NAS) de-
           scribed by Kleiner et al. . Three randomly selected elds per animal[20] fi
          were assessed and analyzed using Pro Plus 5.1 software (Media Cy-
  bernetics, Rockville, MD).
   2.7. Western blot analysis
        Livers were homogenized as previously described . Aliquots of[21]
        total homogenates containing 25 40 g protein were denatured with– μ
       Laemmli bu er, separated by reducing 7.5 12.5% polyacrylamide gelff –
      electrophoresis, and electroblotted to PVDF membranes. Membranes
            were blocked for 2 h in 5% (w/v) bovine serum albumin and subse-
         quently incubated in the presence of the corresponding primary anti-
           bodies (1:1000 dilution) overnight at 4 °C. After incubation for 90 min
         at room temperature in the presence of secondary antibodies (HRP
       conjugated) (1:10,000 dilution), the conjugates were visualized using
 enhanced chemiluminescence.
     2.8. Electrophoretic mobility shift assay (EMSA)
        NF- B-DNA binding was assessed in the nuclear fractions obtainedκ
         from liver as previously described . The EMSA was performed[22,23]
        by end labeling the oligonucleotide containing the consensus sequences
   for NF- B with [ -κ γ 32       P] ATP. The oligonucleotide was end-labeled using
        T4 polynucleotide kinase and puri ed using Chroma Spin-10 columns.fi
      Samples were incubated with the labeled oligonucleotide
          (20,000 30,000 cpm) for 20 min at room temperature in 1X binding–
          bu er [5X binding bu er: 50 mM Tris-HCl bu er, pH 7.5, containingff ff ff
     20% (v/v) glycerol, 5 mM MgCl 2         , 2.5 mM EDTA, 2.5 mM DTT, 250 mM
         NaCl, and 0.25 mg/ml poly(dI-dC)]. The products were separated by
        electrophoresis in a 6% (w/v) non-denaturing polyacrylamide gel using
             0.5 X TBE (45 mM Tris/borate, 1 mM EDTA) as the running bu er. Theff
         gels were dried and the radioactivity quanti ed in a Phosphoimagerfi
      840 (Amersham Pharmacia Biotech. Inc., Piscataway, NJ).
  2.9. Statistical analysis
         Data were analyzed by one-way analysis of variance (ANOVA) using
         Statview 5.0 (SAS Institute Inc., Cary, NC). Fisher least signi cancefi
         di erence test was used to examine di erences between group means.ff ff
       A repeated measure ANOVA with Tukey-Kramer multiple comparison
             test was used to analyze changes in body weight and food intake. A P
          value < 0.05 was considered statistically signi cant. Data are shown asfi
  means ± SEM.
 3. Results
 3.1. Diets
         To prepare the diets containing AC, in particular cyanidin and
            delphinidin, control and high fat diets were added with a blend of berry
         and black rice extracts. The polyphenol composition of the AC-rich
            blend was determined as described in Methods and is shown in .Table 1
           It can be estimated that the AC containing diets provided AC glycosides
      Fig. 2. E ects of supplementation with an
       AC-rich extract on GTT and ITT responses in
        HFD-fed rats. (A) (B)GTT and ITT were per-
         formed on weeks 9 and 11 on the diets, re-
       spectively. Mice were fed a control diet (empty
      triangles, empty bars), the control diet sup-
       plemented with 40 mg AC/kg body weight (full
      triangles, dashed bars), a HFD (black circles,
       black bars), or the HFD supplemented with 2
       (light pink diamonds, light pink bars), 20 (dark
        pink diamonds, dark pink bars), or 40 mg AC/
        kg body weight (red circles, red bars). The area
        under the curve for GTT and ITT tests were
     calculated, values referred to the control
        group, and shown as bars in the right panels.
         Results are shown as means ± SE and are the
     average of 9 10 animals/group. Values having–
    di erent superscripts are signi cantly di erentff fi ff
    (p < 0.05, one-way ANOVA).
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         in the following percentages: 66% cyanidin, 28% delphinidin and 5.6%
     peonidin of the total AC content.
  3.2. Animal outcomes
           Daily food intake in the groups fed the HFD was signi cantly lowerfi
             than in those fed the control and CA diets ( ). However,Table 2, Fig. 1A
           the calorie intake was similar within groups (14.4 and 14.8 kcal/d for
         control- and HFD-fed mice, respectively). Weekly food intake did not
     signi cantly vary within groups ( ).fi Fig. 1A
          Starting at week 4 and through the following weeks, the body
           weight gain for C, CA, and HFA40 groups was signi cantly lower thanfi
            for the HF group ( ). At week 14, there was a dose-dependentFig. 1B
            decrease in body weight depending on the amount of AC in the diet
             ( ). At the end of the study, consumption of the HFD caused aTable 2
          31% higher body weight compared to controls, while the body weight
         of HFA40 mice was 14% lower than in HF mice.
         HFD-induced obesity was associated with an increased weight of the
        di erent fat pads (brown, epididymal, visceral, subcutaneous and ret-ff
          roperitoneal) ( ). HFA40 mice showed a brown fat content si-Table 2
           milar to C mice, and 72% and 49% lower visceral and retroperitoneal
         fat accumulation, respectively, compared to HF mice. Brown fat weight
          in CA mice was 43% higher than in the C group.
        Consumption of the HFD also caused dyslipidemia. Plasma choles-
             terol and triglyceride levels were 26% and 9% higher in HF than in C
         mice, respectively ( ). Supplementation of HFD-fed mice with ACTable 2
         prevented the increase of plasma triglyceride concentrations at all the
        AC concentrations tested, while plasma cholesterol increase was only
         prevented at the highest AC supplementation level, i.e. HFA40 group.
          While there were no signi cant di erences in the amount of tri-fi ff
           glycerides excreted with the feces among the control, HF and CA groups
            (10.2 ± 0.8, 12.0 ± 0.3 and 12.0 ± 0.1 mg/g feces, respectively),
           fecal triglyceride amount in the HFA40 group (15.6 ± 3.6 mg/g feces)
           was signi cantly higher than in the control group (p < 0.04). Fecalfi
           cholesterol content was signi cantly higher (p < 0.05) in the HF andfi
            HFA40 groups (8.0 ± 0.3 and 6 ± 0.8 mg/g feces, respectively) than
            in control and CA groups (2.7 ± 0.1 and 3.2 ± 0.3, respectively).
          3.3. Supplementation with AC improved glucose homeostasis in mice fed a
  high fat diet
         Fasting plasma glucose and insulin were 40% and 130% higher,
            respectively, in the HF compared to the C group. In the HFA40 group,
           both parameters showed values similar to those observed in the C and
            CA groups, while in the HFA2 group only plasma insulin was similar to
           control values ( ). Consumption of the HFD diet altered the re-Table 2
          sponse of mice to insulin (ITT) and glucose (GTT) tolerance tests
               ( ). The area under the curve for the GTT and ITT was 41% andFig. 2A, B 
           24% higher, respectively, in HF than in C and CA mice. Supplementa-
             tion with AC at the highest dose tested caused a 59% reduction of the
            increase in GTT area under the curve, and total prevention of the in-
          crease in ITT area under the curve. Given that supplementation with
                       Fig. 3. E ects of supplementation with an AC-rich blend on hormones relevant to glucose homeostasis in HFD-fed rats. A- B- C-Adiponectin, leptin, GIP and
                             D- GLP-1 were measured in plasma of mice fed for 14 w- a control diet (empty bars), the control diet supplemented with 40 mg AC/kg body weight (dashed bars), a
                            HFD (black bars), or the HFD supplemented with 40 mg AC/kg body weight (red bars). Results are shown as means ± SE and are the average of 9 10 animals/group.–
           Values having di erent superscripts are signi cantly di erent (p < 0.05, one-way ANOVA).ff fi ff
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            40 mg AC/kg body weight was the AC level that provided the strongest
       level of protection against HFD-induced insulin resistance, subsequent
       experiments were focused only on the HFA40 group.
       3.4. Supplementation with AC improved plasma hormone pro les
          We next investigated the levels of select hormones, which are re-
          levant to the regulation of glucose homeostasis, and that are produced
          by the adipose tissue, i.e. adiponectin and leptin, and by gastro-
        intestinal enteroendocrine cells, i.e. GIP and GLP-1. While plasma
         adiponectin levels were similar among groups, plasma leptin was 4
              times higher in the HF compared to the C group ( ). TheFig. 3 A, B
           increase in leptin observed in HF mice was partially (63%) prevented in
         HFA40 mice. HFD consumption caused a signi cant increase (83%) infi
            plasma GIP that was not observed in the HFA40 group ( ).Fig. 3 C
         Plasma GLP-1 concentration was signi cantly higher in HF, HFA40 andfi
           CA groups (57%, 52%, and 98%, respectively) compared to the C group
  ( ).Fig. 3 D
         3.5. Supplementation with AC attenuated steatosis and in ammation in the
       liver of mice fed a high fat diet
        Consumption of the HFD caused steatosis and liver in ammation.fl 
          Liver triglyceride levels were 76% higher in the HFD-fed compared to
            the C group. This increase in liver triglycerides was not observed in the
          HFA40 group. ( ). Lipid deposition was also assessed by histo-Fig. 4A
       logical analysis after hematoxylin-eosin staining ( ). Consump-Fig. 4B
            tion of the HFD caused an increased lipid deposition in the liver that
          was not observed in HFA40 mouse liver. The NAFLD activity score
           (NAS) was signi cantly higher (6.4 folds) in the liver from HF com-fi
        pared to C, CA, and HFA40 mice ( ).Fig. 4C
        Several proteins involved in the in ammatory response were mea-fl
           sured in liver by Western blot ( ). The chemokine MCP-1, theFig. 4D
         cytokine TNF , the macrophage marker F4/80, and the enzyme NOS2α
           were all upregulated in the liver of HF mice. Supplementation with AC
         either partially (MCP-1) or fully (F4/80, TNF , and NOS2) preventedα
         these increases. No signi cant di erences were observed between C andfi ff
       CA in markers of steatosis and liver in ammation.fl
         3.6. Supplementation with AC improved parameters of oxidative stress and
             redox signaling involved in insulin resistance in the liver of mice fed a high
 fat diet
         HFD-associated alterations in glucose homeostasis can be due to an
        upregulation of NADPH oxidase (NOX) isoforms leading to hepatic
         oxidative stress, and the activation of redox-sensitive signals that pro-
         mote insulin resistance. Consumption of the HFD caused the upregu-
          lation of liver NOX2 (gp91phox), NOX3 and NOX4 ( ). Thus,Fig. 5
          gp91phox, NOX3 and NOX4 levels were 43%, 51% and 80% higher,
         respectively, in HF compared to C mice. AC supplementation prevented
      Fig. 4. E ects of supplementation with an
      AC-rich blend on steatosis and hepatic in-
       ammation in HFD-fed rats. Mice were fed a
      control diet (empty bars), the control diet
      supplemented with 40 mg AC/kg body weight
        (dashed bars), a HFD (black bars), or the HFD
      supplemented with 40 mg AC/kg body weight
       (red bars). At week 14 on the corresponding
     diets the following parameters were measured:
       A- B-liver triglyceride content, fat liver de-
    position as evaluated by hematoxylin/eosin
      tissue staining, NAFLD activity score (NAS),C-
     and proteins involved in in ammation:D- fl
      MCP-1, F4/80, TNF , and NOS2. Western blotα
       bands were quanti ed and values referred to -fi β
      actin levels (loading control). Results for CA,
       HF and HFA40 were referred to control group
         values (C). Results are shown as mean ± SE of
     6 animals/group. Values having di erent su-ff
   perscripts are signi cantly di erentfi ff
     (p < 0.05, one-way ANOVA test).
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         HFD-mediated upregulation of NOX3 and NOX4, but not that of
         gp91phox. The increased NOXs expression was paralleled by a 40%
        increase in the levels of 4-hydroxynonenal-protein adducts in HFD-fed
        mice, which was prevented by AC supplementation ( ).Fig. 5
       The phosphorylation of the redox-sensitive signals JNK (Thr183/
         Tyr185) and IKK (Ser176/180) was 84% and 83% higher, respectively,
             in the liver of HF compared to C mice ( ). The increased phos-Fig. 6A
            phorylation of both JNK and IKK was not observed in HFA40 mice. In
          agreement with the activation of IKK, an upstream event in the
         pathway, NF- B-DNA binding, was 52% higher in liver nuclear fractionsκ
             from HF than in C and HFA40 mice ( ). Activation of the NF- BFig. 6B κ
        signaling pathway was associated with an increased expression of
              PTP1B, which in the liver of HF mice was 31% higher than in C and
   HFA40 mice ( ).Fig. 6A
 4. Discussion
           Chronic consumption of a HFD by mice led to the development of
       obesity, adiposity, dyslipidemia, steatosis, liver in ammation and in-fl
          sulin resistance. Simultaneous consumption of a diet rich in AC, i.e.
        cyanidins and delphinidins, attenuated all these adverse e ects. Inff
      addition, the AC-associated improvement of in ammation, oxidativefl
          stress, and insulin sensitivity was in part associated with their capacity
    to modulate NF- B and JNK.κ
           Diets rich in fat and carbohydrates are in part responsible for the
         increasing global burden of overweight and obesity. The dietary con-
           sumption of a HFD by mice mimics the consequences of Western style
           diets in humans. The amount of ACs provided are comparable in quality
         and amount to that achievable through food consumption and/or ra-
         tional amounts of dietary supplements in humans. We observed that
             mice eating the HFD and AC gained less weight than those fed the HFD
          alone, despite consuming similar amounts of calories. In line with these
           results, AC at the highest amount provided, i.e. 40 mg/kg body weight,
           led to lower weight of brown, visceral, and retroperitoneal fat pads, but
        not epididymal or subcutaneous fat, compared to the non-supplemented
           Fig. 5. E ects of supplementation with an AC-rich blend on parameters of
             liver oxidative stress in HFD mice. Mice were fed a control diet (empty bars),
            the control diet supplemented with 40 mg AC/kg body weight (dashed bars), a
            HFD (black bars), or the HFD supplemented with 40 mg AC/kg body weight
           (red bars). At week 14 on the corresponding diets the following parameters
           were measured in liver by Western blot: gp91phox, NOX3, NOX4 and HNE-
          protein adducts, Bands were quanti ed and values referred to -actin levelsfi β
            (loading control. Results for CA, HF and HFA40 were referred to control group
             values (C). Results are shown as mean ± SE of 6 animals/group. Values having
         di erent superscripts are signi cantly di erent (p < 0.05, one-way ANOVAff fi ff
test).
      Fig. 6. E ects of supplementation with an
    AC-rich blend on redox-sensitive signals
     that modulate insulin sensitivity in HFD
       mice. Mice were fed a control diet (empty
     bars), the control diet supplemented with
       40 mg AC/kg body weight (dashed bars), a
      HFD (black bars), or the HFD supplemented
        with 40 mg AC/kg body weight (red bars). At
       week 14 on the corresponding diets the fol-
      lowing parameters were measured in liver: ( )A
      by Western blot: phosphorylation of JNK and
      IKK and PTP1B levels (bands were quanti edfi
       and values referred to total protein levels (JNK,
      IKK) or -actin levels (PTP1B); - NF- B-DNAβ B κ
      binding in liver nuclear fractions measured by
     EMSA. Representative EMSA images are shown
        on the right panel. To assess the speci c bands,fi
       a control nuclear fraction was incubated in the
       presence of a 100-fold molar excess of un-
    labeled oligonucleotide containing the con-
     sensus sequence for a nonspeci c (N.S.)fi
     (FOXO-1) or speci c (S.) (NF- B) transcriptionfi κ
        factor before the binding assay. For both A and
        B, results for CA, HF and HFA40 were referred
       to control group values (C). Results are shown
       as mean ± SE of 6 animals/group. Values
    having di erent superscripts are signi cantlyff fi
      di erent (p < 0.05, one-way ANOVA test).ff
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         HFD-fed mice. AC-mediated decrease in visceral fat is particularly re-
            levant given the role of this fat pad in the development of systemic
         adverse e ects through the release of adipokines, growth factors andff
       in ammatory molecules. Thus, visceral fat accumulation is associatedfl
         with the development of metabolic syndrome and associated dis-[24]
         eases, e.g., NAFLD and cardiovascular disease . AC supple-[25] [26]
       mentation also attenuated the hyperlipidemia and steatosis associated
        with HFD consumption. These results disagree with previous reports
             that pure AC but not AC in berry extracts have the capacity to improve
         dyslipidemia . These di erences may be related to di erences in[27] ff ff
          experimental design, but stress the relevance of the overall food matrix
         in AC absorption and metabolism, and subsequently on their biological
           actions. Part of the mentioned e ects on obesity and steatosis could beff
             due to the actions of AC at the gastrointestinal tract . In this regard,[28]
           factors that can contribute to the capacity of AC to mitigate body
          weight gain and excess tissue lipid deposition may include the mod-
           ulation of GLP-1, a hormone known to reduce adiposity , and/or a[29]
         decreased fat absorption associated to the inhibition of pancreatic li-
          pase, which is essential for dietary triglyceride absorption in the in-
          testine . With regard to the latter, both cyanidin and cyanidin-3,5-[30]
          diglucoside were shown to inhibit the enzyme . Pancreaticin vitro [31]
          lipase inhibition would also be consistent with the current nding offi
        high fecal triglyceride levels in the AC-supplemented and HFD-fed
mice.
         The increasing incidence of T2D worldwide has paralleled that of
        overweight and obesity. As previously reported . HFD con-[32,33]
          sumption by C57BL/6J mice led to insulin resistance as evidenced by
          high fasted plasma glucose and insulin levels, and impaired ITT and
          GTT tests. At the highest concentration tested, the AC blend improved
        all these parameters. Accordingly, an AC-rich blueberry extract was
         found to improve parameters of insulin sensitivity in HFD-fed mice,
           although under the tested conditions the ITT and GTT were not a ectedff
           by fat consumption . The above bene cial e ects could be in part[34] fi ff 
           related to the capacity of AC to modulate hormones that regulate dif-
       ferent aspects of glucose homeostasis. Adipokines (adiponectin, leptin)
          and incretins (GLP-1, GIP) contribute to the regulation of satiety and/or
        glucose homeostasis. While plasma adiponectin levels were not af-
          fected, plasma leptin was increased because of HFD consumption, as it
         is observed in diet-induced obesity , The attenuation of hy-[35]
         perleptinemia by AC supplementation in HFD-fed mice may in part
           re ect a decreased fat pad mass and an improved capacity to modulatefl
            food intake and energy balance. In terms of the incretins, GIP and GLP-
        1 increase insulin secretion after food consumption in uencing glucosefl
        control. Furthermore, GLP-1 promotes satiety and improves basal[36]
         and postprandial lipidemia . The prevention by AC of HFD-medi-[37]
         ated GIP increase may re ect AC-mediated improved capacity to reg-fl
        ulate glucose homeostasis. While AC supplementation did not a ectff
        HFD-mediated increase in plasma GLP-1, it increased GLP-1 plasma
           levels in mice fed the control diet. Consistently with the latter, del-
phinidin          was found to increase GLP-1 secretion in GLUTag cells .[38]
         The capacity of cyanidin and/or delphinidin to increase plasma GLP-1
         may be an important mechanism underlying, in part, their anti-obesity
           and anti-T2D actions. In fact, GLP-1 is a relevant therapeutic target for
    the control of T2D .[29]
            The liver is one of the central organs in the maintenance of glucose
       and lipid homeostasis. HFD consumption disrupted this homeostasis,
          and in parallel caused liver fat deposition and in ammation. The co-fl
      ordinated AC-mediated improvement of HFD-induced liver steatosis,
        in ammation, and systemic insulin resistance can be explained throughfl
         the interplay among these adverse conditions. In terms of biochemical
        mechanisms, in ammation, oxidative stress and the activation of NF- Bfl κ
           are events that establish a self-feeding cycle that can be initiated by
         excess nutrient consumption . The capacity of AC to mitigate[39,40]
       HFD-triggered hepatic in ammation and NF- B/JNK activation can befl κ
            in part due to AC capacity to modulate liver oxidative stress. AC cannot
        exert direct antioxidant actions except at the gastrointestinal tract
          where they can reach high enough concentrations that allow to sca-
            venge oxidants at a signi cant extent . On the other hand, in thefi [41]
           liver and other organs, the regulation of oxidative stress is mainly due
         to indirect antioxidant actions exerted by AC, mainly their metabolites,
          through the modulation of the production of superoxide anion and ni-
          tric oxide . In fact, we observed that AC supplementation prevented[42]
         HFD-mediated upregulation of NOX3 and NOX4, and of the pro-in-
       flammatory inducible nitric oxide synthase, NOS2. AC supplementation
         also prevented the high levels of 4-HNE-protein adducts in HFD-mouse
        liver. Consistently, nutrient overload can cause increased formation of
       4-HNE which irreversibly form adducts with macromolecules (e.g.
          proteins), which can modify cell function, and contribute to T2D and
  NAFLD development .[43]
         Inactivation of the redox sensitive transcription NF- B can be cen-κ
         tral to AC bene cial actions. We observed that AC supplementationfi
         inhibited in the liver HFD-induced NF- B activation, as evidenced byκ
      both decreased IKK phosphorylation, and NF- B-DNA binding.κ
        Accordingly, we previously observed that cyanidin and delphinidin 3-
      O-glucosides inhibited TNF -induced NF- B activation and down-α κ
          stream loss of monolayer integrity in Caco-2 intestinal cells . Cya-[8]
        nidin inhibited the in ammatory response and redox imbalance (glu-fl
         tathione decrease) triggered by TNF in Caco-2 cells, which wasα
          attributed in part to NF- B inhibition and Nrf2 upregulation . NF-κ [44]
           κB and JNK pathways are key players in the development of insulin
          resistance. Activation of the NF- B upstream kinase IKK and ofκ [45]
           JNK leads to the phosphorylation in serine residues of the insulin[9,10]
        receptor substrate-1 (IRS1) causing a downregulation of the insulin
   cascade. In addition, NF-κB      activation also induces the transcription of
        PTP1B , a tyrosine phosphatase which dephosphorylates and in-[46]
           activates the insulin receptor and IRS1. Thus, disruption of the high fat-
        diet induced cycle of in ammation, oxidative stress and NF- B/JNKfl κ
           activation can be central in the capacity of AC to mitigate HFD-induced
           insulin resistance. Furthermore, it can be argued that the e ects of ACff
           on insulin resistance are in part derived from an upstream regulation of
   oxidant levels and/or in ammation.fl
       In summary, supplementation with a cyanidin and delphinidin-rich
        blend, mitigated the adverse consequences of HFD consumption, i.e.
       obesity, dyslipidemia, steatosis, and insulin resistance. Inhibition of
       in ammation, oxidative stress and NF- B/JNK activation emerge asfl κ
       mechanisms underlying those AC-mediated bene ts. In addition, ACfi
          could also act in part by inhibiting pancreatic lipase and subsequently
         dietary lipid absorption, and by modulating incretins involved in glu-
       cose and lipid homeostasis. Increased AC cyanidin/delphinidin con-
          sumption either through diet or by supplementation could be a plau-
          sible strategy to control the adverse e ects of Western style diets.ff
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